​

STAAR Surgical (STAA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

STAA Stock Forecast

STAAR Surgical (STAA) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $54.58, with a high of $85.00 and a low of $45.03. This represents a 223.15% increase from the last price of $16.89.

$15 $29 $43 $57 $71 $85 High: $85 Avg: $54.58 Low: $45.03 Last Closed Price: $16.89

STAA Stock Rating

STAAR Surgical stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (45.45%), 5 Hold (45.45%), 1 Sell (9.09%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 5 5 Strong Sell Sell Hold Buy Strong Buy

STAA Price Target Upside V Benchmarks

TypeNameUpside
StockSTAAR Surgical223.15%
SectorHealthcare Stocks 35.25%
IndustryMedical Instruments & Supplies Stocks34.02%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$46.00
Last Closing Price$16.89$16.89$16.89
Upside/Downside--172.35%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-391-13
Mar, 25-391-13
Feb, 25-751-13
Jan, 251751-14
Dec, 241751-14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 11, 2024Ryan ZimmermanBTIG$46.00$38.0720.83%172.35%
Apr 09, 2024Raj DenhoyJefferies$60.00$50.5918.60%255.24%
Apr 08, 2024John YoungCanaccord Genuity$46.00$48.68-5.51%172.35%
Apr 04, 2024Margaret KaczorWilliam Blair$45.03$45.54-1.12%166.61%
Jan 11, 2023Stephens StephensStephens$85.00$68.5623.98%403.26%
Sep 23, 2022Truist Financial$48.00$71.93-33.27%184.19%
Sep 23, 2022RBC Capital$52.00$73.19-28.95%207.87%
Jul 19, 2022Truist Financial$54.00$74.65-27.66%219.72%
Apr 26, 2022Canaccord Genuity$89.00$59.0250.80%426.94%
Mar 23, 2022Michael CiarmoliTruist Financial$58.00$71.96-19.40%243.40%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 15, 2024Morgan StanleyUnderweightdowngrade
Jun 11, 2024Piper SandlerBuyBuyhold
Apr 09, 2024JefferiesBuyBuyhold
Apr 08, 2024Canaccord GenuityHoldHoldhold
Apr 04, 2024William BlairMarket PerformOutperformupgrade
Apr 04, 2024Stifel NicolausBuyBuyhold
Mar 11, 2024BarclaysUnderperformUnderperformhold
Sep 15, 2023NeedhamBuyBuyhold
Jun 07, 2023William BlairMarket Performdowngrade
Dec 28, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.13$0.52$0.83$0.44-----
Avg Forecast$0.30$0.84$1.22$1.04$0.69$0.75$1.07$1.63$2.09
High Forecast$0.31$0.86$1.27$1.15$0.75$0.94$1.44$1.81$2.25
Low Forecast$0.29$0.81$1.16$0.98$0.65$0.56$0.83$1.45$1.98
Surprise %-56.67%-38.10%-31.97%-57.69%-----

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$163.46M$230.47M$284.39M$322.42M$313.90K----
Avg Forecast$161.74M$230.96M$284.45M$322.11M$342.50M$379.40M$428.25M$525.40M$610.45M
High Forecast$164.60M$235.04M$295.19M$341.03M$344.35M$397.67M$431.61M$531.50M$646.30M
Low Forecast$157.35M$224.68M$274.29M$308.83M$340.78M$364.71M$424.88M$519.30M$585.28M
Surprise %1.06%-0.21%-0.02%0.10%-99.91%----

Net Income Forecast

$-50M $-10M $30M $70M $110M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.91M$27.51M$39.66M$21.35M$-20.21K----
Avg Forecast$5.21M$97.17M$115.79M$21.35M$34.74M$37.12M$56.24M$80.57M$103.30M
High Forecast$6.93M$116.61M$138.94M$25.62M$37.31M$46.63M$71.23M$89.32M$111.19M
Low Forecast$3.49M$77.74M$92.63M$17.08M$32.18M$27.62M$41.24M$71.81M$97.77M
Surprise %13.60%-71.69%-65.74%--100.06%----

STAA Forecast FAQ

Is STAAR Surgical stock a buy?

STAAR Surgical stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that STAAR Surgical is a favorable investment for most analysts.

What is STAAR Surgical's price target?

STAAR Surgical's price target, set by 11 Wall Street analysts, averages $54.58 over the next 12 months. The price target range spans from $45.03 at the low end to $85 at the high end, suggesting a potential 223.15% change from the previous closing price of $16.89.

How does STAAR Surgical stock forecast compare to its benchmarks?

STAAR Surgical's stock forecast shows a 223.15% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical instruments & supplies stocks industry (34.02%).

What is the breakdown of analyst ratings for STAAR Surgical over the past three months?

  • April 2025: 0% Strong Buy, 23.08% Buy, 69.23% Hold, 7.69% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 23.08% Buy, 69.23% Hold, 7.69% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 53.85% Buy, 38.46% Hold, 7.69% Sell, 0% Strong Sell.

What is STAAR Surgical’s EPS forecast?

STAAR Surgical's average annual EPS forecast for its fiscal year ending in December 2025 is $0.75, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $1.07 in 2026, $1.63 in 2027, and $2.09 in 2028.

What is STAAR Surgical’s revenue forecast?

STAAR Surgical's average annual revenue forecast for its fiscal year ending in December 2025 is $379.4M, reflecting a 120764.57% increase from the reported $313.9K in 2024. The forecast for 2026 is $428.25M, followed by $525.4M for 2027, and $610.45M for 2028.

What is STAAR Surgical’s net income forecast?

STAAR Surgical's net income forecast for the fiscal year ending in December 2025 stands at $37.12M, representing a -183802.70% decrease from the reported $-20.208K in 2024. Projections indicate $56.24M in 2026, $80.57M in 2027, and $103.3M in 2028.